SPOP and prostate cancer: Two recent studies have suggested that dysregulation of the SPOP ubiquitin ligase complex in ERG-overexpressing prostate cancer cells reduces ERG ubiquitination, and that stabilized ERG was responsible for the enhanced migration and invasion activities of cells carrying SPOP mutations [2], [30].